Quick Takeaways
- PERCEPTIVE ADVISORS LLC filed SCHEDULE 13D/A for Nautilus Biotechnology, Inc. Common Stock, par value $0.0001 per share (NAUT).
- Disclosed ownership: 10%.
- Date of event: 31 Jan 2025.
PERCEPTIVE ADVISORS LLC - 31 Jan 2025 SCHEDULE 13D/A Report for Nautilus Biotechnology, Inc. Common Stock, par value $0.0001 per share (NAUT)
- Filing Manager
- PERCEPTIVE ADVISORS LLC
- Reporting Manager
- Perceptive Advisors LLC
- Symbol
- NAUT
- Shares outstanding
- 125,942,110 shares
- Disclosed Ownership
- 12,594,211 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13D/A
- Filing time
- 31 Jan 2025, 21:06:27 UTC
- Date of event
- 31 Jan 2025
- Next filing
- 24 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PERCEPTIVE ADVISORS LLC disclosed 10% ownership in Nautilus Biotechnology, Inc. Common Stock, par value $0.0001 per share (NAUT) on 31 Jan 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 31 Jan 2025, 21:06.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Perceptive Advisors LLC | 10% | 12,594,211 | 0 | 12,594,211 | /s/ Joseph Edelman | Joseph Edelman, Managing Member | 0001224962 |
| Joseph Edelman | 10% | 12,594,211 | 0 | 12,594,211 | /s/ Joseph Edelman | Joseph Edelman | 0001164426 |
| Perceptive Life Sciences Master Fund, Ltd. | 9.9% | 12,428,351 | 0 | 12,428,351 | /s/ Joseph Edelman | By Perceptive Advisors LLC, by Joseph Edelman, Managing Member | 0001249675 |